Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study

Trial Profile

Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Dec 2017

At a glance

  • Drugs Glimepiride (Primary) ; Insulin glargine (Primary) ; Liraglutide (Primary) ; Sitagliptin (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Acronyms GRADE
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 13 Dec 2017 Planned End Date changed from 1 Aug 2020 to 1 Jul 2021.
    • 07 Jul 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top